<DOC>
	<DOCNO>NCT01029106</DOCNO>
	<brief_summary>This prospective , non-randomized , observational , multicentre ( 5 site ) study subject surgically-correctable Stress Urinary Incontinence undergo TVT SECUR operative procedure . The study collect preoperative urologic testing , medical history , subject quality life patient questionnaire , Intraoperative procedural data collect . Postoperative complication , urologic , test , subject questionnaire collect interval 24 month . The anatomic position device characterize transvaginal ultrasound test . To determine rate and/or improvement rate patient receive Gynecare Secur device 12 month 24 month .</brief_summary>
	<brief_title>Gynecare TVT Secur Management Stress Urinary Incontinence ( SUI )</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>To consider eligible participate study , subject must meet following requirement : 1 . Subject agree undergo surgical implantation TVT SECUR System 2 . Subject complaint SUI least 6 month prior Preoperative Evaluation Visit . 3 . Subject confirm SUI result urethral hypermobility cough stress test . 4 . Subject least 4 gm urine leakage 1hour pad test Preoperative Screening Visit . 5 . Subject least 18 year age maximum 85 year age 6 . Subject willing able give write informed consent prior study related procedure . 7 . Subject willing return followup evaluation questionnaire completion 46 week , 3 , 6 , 12 24 month followup . 8 . Subject willing undergo transvaginal ultrasound evaluation 4 week 12 month followup visit . Subjects eligible entry study meet one follow criterion : 1 . Subject pregnant . 2 . Subject previous synthetic suburethral sling procedure . 3 . Subject current urinary tract vaginal infection . 4 . Subject blood coagulation disorder . 5 . Subject compromise immune system condition would compromise healing . 6 . Subject upper urinary tract obstruction . 7 . Subject unwilling provide write informed consent . 8 . Subject unwilling unable return evaluation 46 week , 3 , 6 , 12 , 24 month . 9 . Subject uncontrolled detrusor overactivity . 10 . Subject PVR great 100 cc . 11 . Subject Peak Flow Rate le 10 ml/sec . 12 . Subject urethral diverticulum . 13 . Subject significant pelvic organ prolapse ( Grade III/IV ) require surgical treatment . 14 . Subject radiation therapy pelvic area time . 15 . Subject current active history pelvic cancer . 16 . Subject opinion investigator unable and/or unlikely comprehend nature , scope possible consequence study follow study procedure instruction complete study related measurement .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>SUI</keyword>
	<keyword>Stress Urinary Incontinence</keyword>
	<keyword>Patients Stress Urinary Incontinence</keyword>
</DOC>